Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care

Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology

(2018) John E Ripollone et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Reduced Mortality With Sodium-Glucose Cotransporter–2 Inhibitors in Observational Studies

(2018) Samy Suissa   CIRCULATION

Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records

(2018) Elisabetta Patorno et al.   DIABETES OBESITY & METABOLISM

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review

(2018) Subodh Verma et al.   DIABETOLOGIA

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study

(2018) Elisabetta Patorno et al.   BMJ-British Medical Journal

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study

(2018) Elisabetta Patorno et al.   BMJ-British Medical Journal

Use of Health Care Databases to Support Supplemental Indications of Approved Medications

(2018) Michael Fralick et al.   JAMA Internal Medicine

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

(2018) Dae Hyun Kim et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

(2018) Stephen D. Wiviott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study

(2017) Seoyoung C. Kim et al.   Arthritis & Rheumatology

Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

(2016) SV Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

(2015) Jennifer B. Green et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

(2014) Elisabetta Patorno et al.   DIABETOLOGIA

Metrics for covariate balance in cohort studies of causal effects

(2013) Jessica M. Franklin et al.   STATISTICS IN MEDICINE

One-to-many propensity score matching in cohort studies

(2012) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A systematic review of validated methods for identifying heart failure using administrative data

(2012) Jane S. Saczynski et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A combined comorbidity score predicted mortality in elderly patients better than existing scores

(2011) Joshua J. Gagne et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

A basic study design for expedited safety signal evaluation based on electronic healthcare data

(2010) Sebastian Schneeweiss   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE